Hypokalemia is a frequent problem in patients on continuous ambulatory peritoneal dialysis (CAPD) and is affected by multiple factors. To evaluate factors associated with hypokalemia, we studied 68 patients on maintenance CAPD treatment for at least six months. In univariate analysis, patients with hypokalemia were associated with older age and the presence of diabetes mellitus. Serum albumin, calcium-phosphate product, triglyceride, body mass index, protein nitrogen appearance, and lean body mass assessed by creatinine kinetics were significantly lower as compared to those without hypokalemia. Serum C-reactive protein was significantly higher in the patients with hypokalemia. Multivariate stepwise linear regression analysis revealed that the serum albumin level and the ultrafiltration volume at the peritoneal equilibration test were independent factors associated with hypokalemia. This suggests that the serum potassium level may be an important nutritional marker in CAPD patients. Further longitudinal investigation is needed to clarify this relationship.
Introduction
Hypokalemia is a frequent problem in peritoneal dialysis (PD) and found in 10-36% of PD patients 1) . Cellular uptake and bowel loss probably play important roles in the pathogenesis of hypokalemia. However, ongoing losses of potassium into dialysate are also an important contributing factor to hypokalemia. This is compounded further by poor nutritional intake, particularly diets including potassium-rich foods like fruits and vegetables 2) . In most conditions, the plasma potassium concentration varies directly with body potassium stores; total body potassium is a strong predictor of skeletal muscle mass 3) . It was also reported that hypokalemia was associated with malnutrition or severe comorbidity in peritoneal dialysis patients 2) . We performed this cross-sectional study to investigate the clinical characteristics of the patients with hypokalemia and the relationship between serum potassium level and nutritional markers, peritoneal transport status, dialysis adequacy, biocompatibility of PD solution, and other clinical indices.
Materials and Methods
Patient selection
We studied 68 patients with end-stage renal disease (ESRD) who had received maintenance continuous ambulatory peritoneal dialysis (CAPD) treatment for at least six months. Since the peritoneal membrane 
Detection of hypokalemia
In this study, serum electrolyte concentrations, including serum potassium, are represented as the mean values of three consecutive monthly measurements obtained one month before and one month after the date when the PET was performed. Hypokalemia is defined as an average serum potassium level of less than 3.5 mEq/L. Use of medication that might affect potassium balance, including diuretics, angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) was also recorded.
Urea and creatinine kinetics and peritoneal equilibration test
Lean body mass was assessed by creatinine kinetics (LBMcr) 4) . Measurements of urea kinetic variables such as the protein equivalent of nitrogen appearance (PNA), urea nitrogen appearance (UNA), total Kt/V, and standardized creatinine clearance were also performed. The PNA was derived from the urea generation rate using the formula proposed by Bergstrom et al. 5) and was normalized to the ideal body weight of the patients. The PET was performed to assess peritoneal transport characteristics as previously described 6) .
Statistical analysis
Statistical analysis was performed using SPSS for Values are expressed as mean SD or number (%). ± ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; rHuEPO, recombinant human erythropoietin; GDP, glucose degradation product; PET, peritoneal equilibration test; D/P creatinine, dialysate to plasma creatinine. ponent) were significantly lower than those without hypokalemia (Table 3-5) . The serum C-reactive protein (CRP) level was significantly higher in the patients with hypokalemia compared to the patients without hypokalemia (p=0.028) ( Table 3) . Pearson correlation analysis showed that serum potassium correlates (Fig. 2, 3) . In contrast, serum potassium correlates negatively with 4-hour dialysate to plasma (D/P) creatinine (r=-0.253, p= 0.038) (Fig. 4) , total CO2 (r=-0.29, p=0.16), ferritin (r= -0.246, p=0.048), peritoneal creatinine clearance (r= -0.256, p=0.035), and serum CRP levels (r=-0.289, p=0.071) (Fig. 5) .
Multivariate analysis of the factors associated with serum potassium levels
Multivariate stepwise linear regression analysis revealed that the serum potassium level was positivelycorrelated with the ultrafiltration volume at the PET (p=0.017) and serum albumin (p=0.029) after adjusted for factors accepted to be significant; 4-hour D/P creatinine, dialysate urea nitrogen losses, total CO2 level, dialysate creatinine clearance, dialysate protein losses, and LBMcr (Table 6 ).
Discussion
The occurrence of hypokalemia is strongly dependent on the patient population. In otherwise healthy adults not receiving any medication, less than 1% will develop hypokalemia 7) . In CAPD patients, the prevalence of hypokalemia has been found to vary from the 10% to 36% 8) . It was reported that 10-15% of PD patients required potassium supplementation for hypokalemia 9) . In our study, the prevalence of hypokalemia in our center was about 10%, similar to previous studies 9) .
In patients on chronic dialysis, hypokalemia is in- . The external balance includes diminished or absent renal excretion, diminished dietary intake, and increased fractional excretion of potassium in the feces. The mode and frequency of dialysis also affected both internal and external potassium balance 11) . Considered from a standpoint of internal potassium redistribution, the trend of a higher frequency of hypokalemia in diabetic patients in our study is explained by the hypothesis that the insulin hormone stimulated by hyperglycemia together with the continuous peritoneal glucose absorption, could promote an excess of potassium redistribution into the intracellular compartment by activating N ,K -ATPase, which results in active potassium uptake 7) . From the view of external balance, generally dialysis itself is the main source of external loss.
In CAPD, most dialysate solutions contain no potassium and patients dialyzed with such solutions lose 25-30 mEq of potassium per day via CAPD. Because this amount is relatively small when compared to the normal daily uptake (70-80 mEq) 9) , hypokalemia secondary to low potassium ingestion usually occurs only after an extended period of low oral potassium intake. It was reported that serum potassium levels in PD patients were not only associated with nutritional status or severity of coexisting comorbid conditions, but were also an independent prognostic indicator in PD patients 2) . In accordance with this report, we also found that hypokalemia levels were associated with poor nutritional indicators such as lower PNA, body mass index, LBMcr, and serum albumin level.
Protein equivalent of nitrogen appearance computed by urea kinetic modeling is known to reflect the dietary protein intake 5) , which is closely related to dietary potassium intake since dietary protein contains about 1 mEq of potassium per gram 12) . This study also revealed that dialysate urea nitrogen losses were significantly higher in the patients without hypokalemia. This can be probably explained by the nutritional aspect, because dialysate urea nitrogen loss is the main component of PNA. Some high potassium foods are also high in phosphorus; examples include corn, yogurt, milk, and beans 13) . Although not reaching statistical significance, the serum potassium level was associated with the serum phosphate level and also significantly associated with calcium-phosphate, indirectly suggesting that hypokalemic patients had an overall reduction in general oral intake.
Serum CRP is an acute-phase protein that is a marker for underlying systemic inflammation. The prevalence of an increased CRP and other pro-inflammatory cytokines (interleukin-1, interleukin-6 and tumor necrosis factor-) was reported to be high in ⍺ dialysis and pre-dialysis patients 14) . It is well documented that high levels of pro-inflammatory cytokines may cause muscle wasting by stimulating protein catabolism via the ubiquitin-proteosome pathway 15) and by inhibiting appetite 16) ; they are also associated with a higher cardiovascular mortality in ESRD patients 17) .
Qureshi et al. showed a close relationship between CRP
and nutritional status as assessed by SGA (subjective global assessment) 18) . Noh et al. reported that serum CRP is an independent predictor of two-year patient survival in CAPD patients 19) . Recently, it was reported that malnutrition-inflammation scores including serum albumin level, total iron binding capacity level, BMI, etc.
correlated significantly with clinical, nutritional, inflammatory, and anthropometric parameters in PD patients, even more strongly than SGA 20) . In our study, we also found that the patients with hypokalemia had a significantly higher CRP level; that level was negatively related to the serum albumin level (r=-0.29, p=0.07) (Fig. 3) and serum potassium level (r=-0.289, p=0.071) (Fig. 5 ), but these two correlations were not statistically significant. In addition, the higher levels of ferritin in the patients with hypokalemia in our study might also be explained in terms of an inflammatory marker.
The creatinine kinetic approach to lean body mass (LBM) estimation was reported to correlate well with other techniques for lean body mass, such as bioimpedance, infrared, and anthropometric measurements 4) .
We found that the patients with hypokalemia had significantly lower LBM levels than those without hypokalemia and that serum potassium levels correlated significantly with LBM levels (r=0.31, p=0.01). The total amount of potassium in the plasma did correlate with total body potassium in normal subjects 21) , and was expected to bear close relationship to plasma potassium especially when maintained for sufficient time at steady levels 22) . A decrease in total body potassium could either reflect a diminishing cellular mass, which is likely to be present in malnutrition, or a change in membrane function that is common in uremia 23)
.
The ultrafiltration volume at the PET was significantly lower in patients with hypokalemia than those without hypokalemia (Table 2 ) and showed a positive correlation with serum potassium levels both significantly and independently ( Fig. 2 ; Table 6 ), consistent with the significant negative correlation between serum potassium level and 4-hour D/P creatinine (Fig.   4 ). This is explained by both the higher rate of diffu- . We also showed in our study that lower ultrafiltration volume at a PET with higher 4-hour D/P creatinine is associated with hypokalemia, probably reflecting volume overload with poor nutritional status. We did not find any correlation between serum potassium level and daily exchange volume or the dialysis adequacy index Kt/V, as with a previous study done by Szeto et al. 2) .
It has been well established that serum albumin level is a strong predictor of increased risk of morbidity and mortality in peritoneal dialysis patients 26) . . In addition to these factors, CAPD patients are uniquely susceptible to the adverse effects on levels of serum albumin because of protein losses into the peritoneal effluent. Our study showed that the patients with hypokalemia had significantly lower serum albumin levels than those without hypokalemia and that the serum albumin levels correlated significantly with serum potassium levels 
